Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 7067 | 1333 | 33.6 | 59% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AEBS | Author keyword | 8 | 75% | 0% | 6 |
| 2 | ANTIESTROGEN BINDING SITES | Author keyword | 8 | 100% | 0% | 5 |
| 3 | ANALOG II | Author keyword | 6 | 80% | 0% | 4 |
| 4 | TAMOXIFEN DERIVATIVES | Author keyword | 6 | 71% | 0% | 5 |
| 5 | TAT 59 | Author keyword | 3 | 57% | 0% | 4 |
| 6 | ANTIESTROGEN BINDING SITE | Author keyword | 3 | 100% | 0% | 3 |
| 7 | FLUOROTAMOXIFEN | Author keyword | 2 | 67% | 0% | 2 |
| 8 | TAMOXIFEN ANALOGUES | Author keyword | 2 | 67% | 0% | 2 |
| 9 | EQUIPE METAB ONCOGENESE DIFFERENCIAT CELLULAIRE | Address | 2 | 50% | 0% | 3 |
| 10 | TRIPHENYLETHYLENES | Author keyword | 2 | 40% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AEBS | 8 | 75% | 0% | 6 | Search AEBS | Search AEBS |
| 2 | ANTIESTROGEN BINDING SITES | 8 | 100% | 0% | 5 | Search ANTIESTROGEN+BINDING+SITES | Search ANTIESTROGEN+BINDING+SITES |
| 3 | ANALOG II | 6 | 80% | 0% | 4 | Search ANALOG+II | Search ANALOG+II |
| 4 | TAMOXIFEN DERIVATIVES | 6 | 71% | 0% | 5 | Search TAMOXIFEN+DERIVATIVES | Search TAMOXIFEN+DERIVATIVES |
| 5 | TAT 59 | 3 | 57% | 0% | 4 | Search TAT+59 | Search TAT+59 |
| 6 | ANTIESTROGEN BINDING SITE | 3 | 100% | 0% | 3 | Search ANTIESTROGEN+BINDING+SITE | Search ANTIESTROGEN+BINDING+SITE |
| 7 | FLUOROTAMOXIFEN | 2 | 67% | 0% | 2 | Search FLUOROTAMOXIFEN | Search FLUOROTAMOXIFEN |
| 8 | TAMOXIFEN ANALOGUES | 2 | 67% | 0% | 2 | Search TAMOXIFEN+ANALOGUES | Search TAMOXIFEN+ANALOGUES |
| 9 | TRIPHENYLETHYLENES | 2 | 40% | 0% | 4 | Search TRIPHENYLETHYLENES | Search TRIPHENYLETHYLENES |
| 10 | CAS 10540 29 1 | 1 | 50% | 0% | 2 | Search CAS+10540+29+1 | Search CAS+10540+29+1 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANALOG II | 13 | 80% | 1% | 8 |
| 2 | NONSTEROIDAL ANTIESTROGENS | 11 | 60% | 1% | 12 |
| 3 | ANTI ESTROGENS | 9 | 30% | 2% | 25 |
| 4 | TRIPHENYLACRYLONITRILE ANTIESTROGENS | 8 | 100% | 0% | 5 |
| 5 | HIGH DOSE TAMOXIFEN | 7 | 21% | 2% | 31 |
| 6 | ANTIESTROGEN BINDING SITES | 7 | 43% | 1% | 12 |
| 7 | INTRACELLULAR HISTAMINE ANTAGONIST | 7 | 67% | 0% | 6 |
| 8 | ESTROCOLYONE I | 6 | 80% | 0% | 4 |
| 9 | STILBENEDIOL | 6 | 80% | 0% | 4 |
| 10 | ANTICANCER DRUG TAMOXIFEN | 5 | 55% | 0% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| ENDOCRINE PHARMACOLOGY OF ANTIESTROGENS AS ANTITUMOR AGENTS | 1990 | 356 | 307 | 36% |
| TAMOXIFEN - NEW MEMBRANE-MEDIATED MECHANISMS OF ACTION AND THERAPEUTIC ADVANCES | 1994 | 109 | 37 | 35% |
| Mechanisms of tamoxifen-induced apoptosis | 2001 | 221 | 108 | 19% |
| BIOCHEMICAL PHARMACOLOGY OF ANTIESTROGEN ACTION | 1984 | 385 | 130 | 61% |
| ESTROGENIC REGULATION OF GROWTH AND POLYPEPTIDE GROWTH-FACTOR SECRETION IN HUMAN-BREAST CARCINOMA | 1987 | 574 | 120 | 24% |
| Estrogen mitogenic action. III. Is phenol red a "red herring"? | 2000 | 26 | 83 | 49% |
| A two-site model for antiestrogen action | 2004 | 14 | 16 | 44% |
| THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN | 1984 | 696 | 165 | 24% |
| Tamoxifen as a potential treatment of glioma | 1998 | 14 | 50 | 42% |
| TAMOXIFEN RESISTANCE IN BREAST-CANCER | 1993 | 39 | 79 | 38% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EQUIPE METAB ONCOGENESE DIFFERENCIAT CELLULAIRE | 2 | 50% | 0.2% | 3 |
| 2 | TEAM STEROL METAB THER EUT INNOVAT ONCOL | 2 | 43% | 0.2% | 3 |
| 3 | ENDOCRINOL CELLULAR COMMUN | 1 | 100% | 0.2% | 2 |
| 4 | ENDOCRINOL MOLEC | 1 | 50% | 0.2% | 2 |
| 5 | IST CNR CHIM RICONOSCIMENTO MOL | 1 | 50% | 0.2% | 2 |
| 6 | 1209 W CALIF ST | 1 | 50% | 0.1% | 1 |
| 7 | BIOL ORGAN CHEM GRP | 1 | 50% | 0.1% | 1 |
| 8 | C REGAUD | 1 | 50% | 0.1% | 1 |
| 9 | CPTP CLAUDIUS REGAUD | 1 | 50% | 0.1% | 1 |
| 10 | DR ALMP | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000211021 | TAMOXIFEN//TOREMIFENE//DROLOXIFENE |
| 2 | 0.0000199512 | ENDOXIFEN//DESMETHYLTAMOXIFEN//N DESMETHYL TAMOXIFEN |
| 3 | 0.0000166974 | LEHRSTUHL PHARMAZEUT CHEM 2//GRP RECH ONCOL ENDOCRINOL MOL//PORPHYRIN PLATINUM CONJUGATES |
| 4 | 0.0000159602 | ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT |
| 5 | 0.0000115641 | BREAST CARCINOMA CELL LINE//BIOTINYLATED EPIDERMAL GROWTH FACTOR//BREAST CANCER BIOPSIES |
| 6 | 0.0000113210 | SHIONOGI CARCINOMA 115//VITAMIN B 12B//CLIN EXPT PATHOPHYSIOL |
| 7 | 0.0000111558 | CENTCHROMAN//DL111 IT//ORMELOXIFENE |
| 8 | 0.0000105487 | UTERINE AGGLUTININ//SIALIC ACID BINDING PROTEIN//MERCAPTOMETHYLIMIDAZOLE AND GASTRIC ACID SECRETION |
| 9 | 0.0000103763 | CRLC OSCAR LAMBRET//UKRAINIAN ONCOL RADIOL//6 METHYL 1 3 8 TRICHLORODIBENZOFURAN |
| 10 | 0.0000099895 | ESTROGENIC RECRUITMENT//AMINOGLUTETHIMIDE//CYCLIC TREATMENT |